BDSX logo

Biodesix (BDSX) Selling, General & Administrative Expenses

Annual SG&A

$67.39 M
+$5.92 M+9.64%

31 December 2023

BDSX Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly SG&A

$20.02 M
+$356.00 K+1.81%

30 September 2024

BDSX Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM SG&A

-$1.75 B
-$43.82 M-2.57%

30 September 2024

BDSX TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BDSX Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9.6%+29.2%-2684.0%
3 y3 years+93.3%+47.1%-3671.8%
5 y5 years+160.2%+143.7%-10000.0%

BDSX Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+93.3%-2.6%+47.6%-60.6%at low
5 y5 yearsat high+160.2%-2.6%+205.3%-669.8%at low
alltimeall timeat high+160.2%-2.6%+205.3%-669.8%at low

Biodesix Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sept 2024
-
$20.02 M(+1.8%)
$76.48 M(+6.3%)
June 2024
-
$19.66 M(-4.4%)
$71.96 M(+4.4%)
Mar 2024
-
$20.56 M(+26.5%)
$68.95 M(+2.3%)
Dec 2023
$67.39 M(+9.6%)
$16.25 M(+4.9%)
$67.39 M(-0.6%)
Sept 2023
-
$15.50 M(-6.9%)
$67.76 M(+0.6%)
June 2023
-
$16.65 M(-12.3%)
$67.38 M(+2.1%)
Mar 2023
-
$18.99 M(+14.2%)
$65.96 M(+7.3%)
Dec 2022
$61.46 M(+21.7%)
$16.63 M(+10.0%)
$61.46 M(+5.3%)
Sept 2022
-
$15.11 M(-0.8%)
$58.39 M(+2.6%)
June 2022
-
$15.23 M(+5.2%)
$56.89 M(+7.2%)
Mar 2022
-
$14.49 M(+6.9%)
$53.08 M(+5.1%)
DateAnnualQuarterlyTTM
Dec 2021
$50.52 M(+44.9%)
$13.56 M(-0.4%)
$50.52 M(+3.0%)
Sept 2021
-
$13.61 M(+19.1%)
$49.02 M(+13.2%)
June 2021
-
$11.43 M(-4.2%)
$43.30 M(+11.9%)
Mar 2021
-
$11.93 M(-1.1%)
$38.70 M(+11.0%)
Dec 2020
$34.86 M(+13.8%)
$12.06 M(+53.1%)
$34.86 M(+18.8%)
Sept 2020
-
$7.88 M(+15.3%)
$29.35 M(-1.1%)
June 2020
-
$6.83 M(-15.4%)
$29.68 M(+29.9%)
Mar 2020
-
$8.08 M(+23.2%)
$22.85 M(+54.7%)
Dec 2019
$30.64 M(+18.3%)
$6.56 M(-20.2%)
$14.77 M(+79.8%)
Sept 2019
-
$8.21 M
$8.21 M
Dec 2018
$25.90 M
-
-

FAQ

  • What is Biodesix annual selling, general & administrative expenses?
  • What is the all time high annual SG&A for Biodesix?
  • What is Biodesix annual SG&A year-on-year change?
  • What is Biodesix quarterly selling, general & administrative expenses?
  • What is the all time high quarterly SG&A for Biodesix?
  • What is Biodesix quarterly SG&A year-on-year change?
  • What is Biodesix TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for Biodesix?
  • What is Biodesix TTM SG&A year-on-year change?

What is Biodesix annual selling, general & administrative expenses?

The current annual SG&A of BDSX is $67.39 M

What is the all time high annual SG&A for Biodesix?

Biodesix all-time high annual selling, general & administrative expenses is $67.39 M

What is Biodesix annual SG&A year-on-year change?

Over the past year, BDSX annual selling, general & administrative expenses has changed by +$5.92 M (+9.64%)

What is Biodesix quarterly selling, general & administrative expenses?

The current quarterly SG&A of BDSX is $20.02 M

What is the all time high quarterly SG&A for Biodesix?

Biodesix all-time high quarterly selling, general & administrative expenses is $20.56 M

What is Biodesix quarterly SG&A year-on-year change?

Over the past year, BDSX quarterly selling, general & administrative expenses has changed by +$4.52 M (+29.17%)

What is Biodesix TTM selling, general & administrative expenses?

The current TTM SG&A of BDSX is -$1.75 B

What is the all time high TTM SG&A for Biodesix?

Biodesix all-time high TTM selling, general & administrative expenses is $76.48 M

What is Biodesix TTM SG&A year-on-year change?

Over the past year, BDSX TTM selling, general & administrative expenses has changed by -$1.82 B (-2684.01%)